Published in J Vasc Interv Radiol on August 01, 2005
Fibrolase: trials and tribulations. Toxins (Basel) (2010) 0.86
Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites. Toxins (Basel) (2016) 0.75
The evolution of recombinant thrombolytics: Current status and future directions. Bioengineered (2016) 0.75
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Virchow's triad revisited. South Med J (2004) 2.23
A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg (2007) 2.22
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. J Clin Oncol (2012) 2.13
Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA (2002) 1.99
Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care (2002) 1.88
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol (2006) 1.83
Renal artery pseudoaneurysm following laparoscopic partial nephrectomy. Urology (2009) 1.82
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med (2004) 1.79
Revisiting the appropriateness of carotid endarterectomy. Stroke (2003) 1.78
A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol (2010) 1.75
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60
Improvement in the visualization of superficial arm veins being evaluated for access and bypass. J Vasc Surg (2005) 1.59
Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg (2009) 1.58
Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr Blood Cancer (2009) 1.48
Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease. Arch Surg (2010) 1.46
Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO). J Vasc Surg (2010) 1.46
Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood (2002) 1.44
Retained fibrin sheaths: chest computed tomography findings and clinical associations. J Thorac Imaging (2014) 1.39
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res (2009) 1.36
Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease. Cancer (2004) 1.30
Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg (2009) 1.17
Isolated internal jugular vein thrombosis: risk factors and natural history. Vasc Med (2002) 1.11
Hypoplasia of the descending thoracic and abdominal aorta: a report of two cases and review of the literature. J Vasc Surg (2002) 1.10
Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Repair Regen (2009) 1.05
Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg (2002) 1.04
Interpretation of the international normalised ratio in patients with liver disease. Lancet (2002) 1.01
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother Pharmacol (2012) 1.01
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study. Cancer (2009) 1.01
Safety of carbon dioxide digital subtraction angiography. Arch Surg (2011) 1.00
Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998-2006. J Vasc Surg (2010) 1.00
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia. Cancer (2009) 0.99
Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol (2009) 0.99
Patches for carotid artery endarterectomy: current materials and prospects. J Vasc Surg (2009) 0.98
Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg (2009) 0.95
Endovascular management of hepatic artery pseudoaneurysm hemorrhage complicating pancreaticoduodenectomy. J Vasc Surg (2006) 0.95
Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro. Am J Physiol Heart Circ Physiol (2004) 0.95
Endovascular management of mycotic aortic aneurysms and associated aortoaerodigestive fistulas. Ann Vasc Surg (2008) 0.94
Arch and visceral/renal debranching combined with endovascular repair for thoracic and thoracoabdominal aortic aneurysms. J Vasc Surg (2011) 0.94
Pancreatic endocrine tumor coexistent with serous microcystic adenoma: report of a case and review of the literature. Ann Diagn Pathol (2005) 0.94
Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining. J Pharmacol Toxicol Methods (2006) 0.93
Concomitant vascular procedures for malignancies with vascular invasion. Arch Surg (2002) 0.93
Clinical use of topical thrombin as a surgical hemostat. Biologics (2008) 0.93
Subintimal angioplasty for chronic arterial occlusions. Tech Vasc Interv Radiol (2004) 0.93
Massive upper GI bleeding in a long-term hemodialysis patient. Chest (2005) 0.92
Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg (2003) 0.92
Internal jugular, subclavian, and axillary deep venous thrombosis and the risk of pulmonary embolism. Vascular (2008) 0.92
Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol (2002) 0.91
Percutaneous gastrostomy of the excluded gastric segment after Roux-en-Y gastric bypass surgery. J Vasc Interv Radiol (2007) 0.91
Endovascular management of hoarseness due to a thoracic aneurysm: case report and review of the literature. Vasc Endovascular Surg (2008) 0.90
Carbon dioxide digital subtraction angiography-assisted endovascular aortic aneurysm repair in the azotemic patient. J Vasc Surg (2007) 0.89
Prevention of vascular access hand ischemia using the axillary artery as inflow. J Vasc Surg (2013) 0.89
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1. Circulation (2002) 0.89
Endovascular grafts and other catheter-directed techniques in the management of ruptured abdominal aortic aneurysms. Semin Vasc Surg (2003) 0.89
Recognition and management of major vessel injury during laparoscopy. J Minim Invasive Gynecol (2010) 0.89
Assessing the performance of surgical teams. Health Care Manage Rev (2008) 0.88
Disease progression after initial surgical intervention for Takayasu arteritis. J Vasc Surg (2011) 0.87
Race independently impacts outcome of infrapopliteal bypass for symptomatic arterial insufficiency. Vasc Endovascular Surg (2007) 0.87
Diagnosis of venous thromboembolic disease in cancer patients. Oncology (Williston Park) (2003) 0.86
Endovascular management of iliac vein occlusive disease. Ann Vasc Surg (2004) 0.86
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Am Heart J (2003) 0.86
Basilic vein transposition fistula: a good option for maintaining hemodialysis access site options? J Vasc Surg (2004) 0.86
Current trends in the management of iatrogenic cervical carotid artery injuries. Vasc Endovascular Surg (2006) 0.86
Repair of a high-flow iliac arteriovenous fistula using a thoracic endograft. J Vasc Surg (2009) 0.86
Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol (2002) 0.86
Clinical outcomes and implications of failed infrainguinal endovascular stents. J Vasc Surg (2011) 0.85
Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail (2010) 0.85
Rupture of a previously thrombosed thoracoabdominal aneurysm. Ann Vasc Surg (2003) 0.85
Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. J Clin Oncol (2006) 0.84
To clot or not to clot: are there predictors of clinically significant thrombus formation in patients with gastroparesis and prolonged IV access? Dig Dis Sci (2008) 0.84
The effects of shoulder laxity on upper extremity blood flow in professional baseball pitchers. J Shoulder Elbow Surg (2010) 0.84
Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study. Radiology (2005) 0.84
Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J Vasc Surg (2003) 0.83
Clinical importance of the "seat belt sign" in blunt trauma to the neck. Am Surg (2002) 0.83
The optimal initial choice for permanent arteriovenous hemodialysis access. J Vasc Surg (2013) 0.83
Rectus sheath hematoma secondary to a tussive paroxysm. J La State Med Soc (2008) 0.83
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. J Am Coll Cardiol (2007) 0.83
Regional quality groups in the Society for Vascular Surgery® Vascular Quality Initiative. J Vasc Surg (2013) 0.83
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Thromb Haemost (2004) 0.82
A 30-year odyssey with the umbilical vein graft. J Am Coll Surg (2006) 0.82
Treatment of ruptured abdominal aneurysms with stent grafts: a new gold standard? Semin Vasc Surg (2003) 0.82
A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma. Melanoma Res (2008) 0.82
Impact of race on infrainguinal angioplasty and stenting. Ann Vasc Surg (2011) 0.82
Non-clinical and clinical characterization of a novel acting thrombolytic: alfimeprase. Pathophysiol Haemost Thromb (2005) 0.82
Surgical teams: role perspectives and role dynamics in the operating room. Health Serv Manage Res (2011) 0.81
Respiratory distress resulting from gastroesophageal reflux is not asthma, but laryngotracheal irritation, spasm, even suffocation. Chin Med Sci J (2009) 0.81
Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads. J Vasc Interv Radiol (2012) 0.81
Current status of thrombolysis for peripheral arterial occlusive disease. Ann Vasc Surg (2002) 0.81
Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. J Vasc Surg (2003) 0.80
The results of a needs assessment to guide a vascular surgery skills simulation curriculum. Ann Vasc Surg (2012) 0.80
Treatment options for traumatic pseudoaneurysms of the paravisceral abdominal aorta. Ann Vasc Surg (2005) 0.80
Communicating respectfully with American Indian and Alaska natives: lessons from the California Health Interview Survey. J Cancer Educ (2005) 0.80
Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia. J Vasc Surg (2008) 0.80
Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia. J Clin Pharmacol (2013) 0.80
Studying ischemia and reperfusion in isolated neonatal rat ventricular myocytes using coverslip hypoxia. Methods Mol Med (2007) 0.79
Acute arterial occlusion secondary to trauma. Semin Vasc Surg (2009) 0.79